ZEB2 and melanoma: Mechanistically, it was shown that the BRAF inhibitor induces activation of Zeb2, which stimulates Mer tyrosine kinase (MerTK) through target of rapamycin complex (TORC)1-triggered activation of autophagy leading to secondary resistance to BRAF inhibition and melanoma cell growth [25].